NOT-TR-23-005: Notice of Termination for PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Notice of Termination for PAR-22-122: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Notice Number:

NOT-TR-23-005

Key Dates

Release Date:

January 6, 2023

Related Announcements

PAR-22-122 - Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

This Notice informs applicants of the early termination for Funding Opportunity Announcement (FOA) PAR-22-122: “Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)". Due to the termination of PAR-22-122, letter of intent and the June 21, 2023 application due date are eliminated, effective immediately. No additional receipt dates will be issued for this FOA.

Inquiries

Please direct all inquiries to:

Audie Atienza, PhD.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-529-7203
Email: audie.atienza@nih.gov